Day: September 23, 2022

ILUVIEN or faricimab (6.0 mg) injections versus observation will be studied for the prevention of visual acuity loss due to radiation retinopathy ATLANTA, Sept. 23, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that it has entered into an agreement with the Jaeb Center for Health Research Foundation Inc. (JCHR), acting on the behalf of the DRCR Retina Network to support and provide ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg sustained release intravitreal implant for “A Randomized Clinical Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants...

REDWOOD CITY, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will be participating in the following conferences in September.Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference (New York City) Ronald Martell, CEO, will participate in a panel titled Addressing Challenges in Cell Therapy and TransplantWednesday, September 28th, 2022, at 9:00AM ET Registration details available here.William Blair Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event Wendy Pang, SVP, Research and Translational Medicine will give a Corporate Presentation.Thursday, September 29th, 2022, at 5:00 PM ET Registration details available here.Details for live and...

Full-Year Extension to Help U.S. Consumers Manage Financial Health During Period of Rising Inflation and Continued Economic Uncertainty ATLANTA and COSTA MESA, Calif. and CHICAGO, Sept. 23, 2022 (GLOBE NEWSWIRE) — The three nationwide credit reporting agencies – Equifax® (NYSE:EFX), Experian (LON:EXPN) and TransUnion (NYSE:TRU) – are taking joint action to continue offering free weekly credit reports to consumers in the United States through the end of 2023. This benefit will help consumers manage their financial health during a period of rising inflation and unprecedented economic uncertainty coming out of the COVID-19 pandemic. The companies’ CEOs provided a joint statement on the decision to extend free weekly credit reports through 2023. “The rising cost of living in the wake of COVID-19 has created economic consequences...

VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), owner of Netcoins (Netcoins.ca) (“Netcoins”), the online cryptocurrency brokerage that makes it easy for Canadians to buy, sell, and understand cryptocurrency, and owner of Blockchain Intelligence Group (blockchaingroup.io) (“BIG”), a leading developer of blockchain technology search, risk-scoring and data analytics solutions, is pleased to announce that its portfolio company TerraZero Technologies Inc. (“TerraZero”) has signed a letter of intent (“LOI”) with Whatcom Capital II Corp. which would result in TerraZero becoming publicly traded via a reverse take-over (“RTO”) transaction. Full details of the LOI can be found here:https://www.newsfilecorp.com/release/138117 Dan...

REDWOOD CITY, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that data from the OPTIC trial of ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022) in wet age-related macular degeneration (wet AMD) will be presented next week during the Late Breaking Developments portion of Retinal Subspecialty Day at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting in Chicago, Illinois. In addition to reviewing the durable efficacy and safety demonstrated out to 104 weeks in the OPTIC Study, the presentation will include new analyses of intraretinal fluid (IRF) and subretinal fluid (SRF) after a single, in-office, intravitreal (IVT) injection...

SYDNEY, AUSTRALIA, Sept. 23, 2022 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce it has received a €1,804,341 (~ A$2,693,046 ) research and development (R&D) tax incentive payment in cash from the French Government under its Crédit d’Impôt Recherche scheme (CIR). The “Crédit d’Impôt Recherche” (CIR), meaning “Research Tax Credit”, is a French government tax incentive by which French companies conducting research and development activities in Europe can be reimbursed 30% of their eligible expenditure. Immutep qualifies to receive the CIR tax incentive through its subsidiary Immutep S.A.S. due to the research and development conducted in its...

SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT). Bionano Laboratories recently received CLIA-certification for its lab in San Diego. This certification will enable Bionano Laboratories to offer services to customers seeking to implement OGM into their diagnostic routines and for research applications with hospitals, pharmaceutical companies, and other parties that may desire a more robust regulatory structure for their projects. A key strategic objective of Bionano Laboratories’ CLIA lab is to develop a menu...

MONTREAL, Sept. 23, 2022 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) is pleased to announce the completion of its previously announced acquisition of two UK-based businesses: Capita Real Estate and Infrastructure Ltd. (“Capita REI”) and GL Hearn Ltd. (“GLH”), both owned by Capita plc. Capita REI is a leading provider of specialist advisory, design, engineering, environmental and project management services for land, building and infrastructure owners, while GLH provides cross-sector advice to developers and investors. Together, both businesses will add about 1,000 UK-based employees to WSP’s workforce, reinforcing its existing service offering within the country and expanding its strategic advisory offering. “I would like to extend a warm welcome to our 1,000 new experts from...

1-year interim data from the 2-year Phase 1b/2 trial of LBS-008 in adolescent STGD1 to be presentedSAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, today announced that the 1-year interim data from the 2-year Phase 1b/2 trial of LBS-008 in adolescent STGD1 will be presented at the “Late Breaking Development” session at the American Academy of Ophthalmology Annual Meeting (AAO 2022) being held September 30 – October 3, 2022 in Chicago. Details of the presentation are as follows: Title: A 2-year Phase 1b/2 Study of the Safety and Tolerability of Tinlarebant in Adolescent STGD1 Subjects: Interim FindingsAbstract Number: 30071744Section: Section X, Late Breaking Developments, Part...

TORONTO, Sept. 23, 2022 (GLOBE NEWSWIRE) — Today Glencore International AG (“Glencore”) announced, and has made Yamana Gold Inc. (TSX:YRI; NYSE:AUY; LSE:AUY) (“Yamana” or the “Company”) aware under the terms of the MARA joint venture (“MARA JV”), that it has reached an agreement (the “Agreement”) to acquire Newmont Corporation’s (“Newmont”) 18.75% shareholding in the MARA Project (“MARA” or the “Project”). Following completion of the Agreement, Yamana remains the MARA JV operator with a 56.25% interest in MARA, with Glencore owning the remaining 43.75%. Yamana welcomes Glencore’s increased stake in the Project and believes the Agreement is a positive step for MARA, as the consolidation of ownership amongst partners provides a further endorsement of the quality and strategic optionality inherent in the Project, as well as underpinning...